FDA Greenlights Inhaled Dual-Action COPD MedicationÂ
The inhaled therapy for the maintenance treatment of COPD combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule.
The inhaled therapy for the maintenance treatment of COPD combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule.
An inactive agent used in beta-agonist inhalers to treat asthma can reverse the beneficial anti-inflammatory effects of inhaled steroids.